-
1دورية أكاديمية
المؤلفون: Motzer, Robert J, Ravaud, Alain, Patard, Jean-Jacques, Pandha, Hardev S, George, Daniel J, Patel, Anup, Chang, Yen-Hwa, Escudier, Bernard, Donskov, Frede, Magheli, Ahmed, Carteni, Giacomo, Laguerre, Brigitte, Tomczak, Piotr, Breza, Jan, Gerletti, Paola, Lechuga, Mariajose, Lin, Xun, Casey, Michelle, Serfass, Lucile, Pantuck, Allan J, Staehler, Michael
المصدر: European Urology. 73(1)
مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Kidney Disease, Clinical Trials and Supportive Activities, Clinical Research, Cancer, Genetics, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Aged, Angiogenesis Inhibitors, Carcinoma, Renal Cell, Chemotherapy, Adjuvant, Disease-Free Survival, Female, Humans, Indoles, Kaplan-Meier Estimate, Kidney Neoplasms, Male, Middle Aged, Nephrectomy, Proportional Hazards Models, Pyrroles, Risk Factors, Sunitinib, Time Factors, Treatment Outcome, Adjuvant, Disease-free survival, Renal cell carcinoma, Urology & Nephrology, Clinical sciences
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/00w563m5Test
-
2دورية أكاديمية
المؤلفون: Louise M Binderup, Marie, Smerdel, Maja, Borgwadt, Line, Beck Nielsen, Signe Sparre, Madsen, Mia Gebauer, Møller, Hans Ulrik, Kiilgaard, Jens Folke, Friis-Hansen, Lennart, Harbud, Vibeke, Cortnum, Søren, Owen, Hanne, Gimsing, Steen, Friis Juhl, Henning Anker, Munthe, Sune, Geilswijk, Marianne, Rasmussen, Åse Krogh, Møldrup, Ulla, Graumann, Ole, Donskov, Frede, Grønbæk, Henning, Stausbøl-Grøn, Brian, Schaffalitzky de Muckadell, Ove, Knigge, Ulrich, Dam, Gitte, Wadt, Karin AW, Bøgeskov, Lars, Bagi, Per, Lund, Lars, Stochholm, Kirstine, Ousager, Lilian Bomme, Sunde, Lone
المصدر: Louise M Binderup , M , Smerdel , M , Borgwadt , L , Beck Nielsen , S S , Madsen , M G , Møller , H U , Kiilgaard , J F , Friis-Hansen , L , Harbud , V , Cortnum , S , Owen , H , Gimsing , S , Friis Juhl , H A , Munthe , S , Geilswijk , M , Rasmussen , Å K , Møldrup , U , Graumann , O , Donskov , F , Grønbæk , H , Stausbøl-Grøn , B , Schaffalitzky de Muckadell , O ....
مصطلحات موضوعية: Guideline, Hemangioblastoma, Pheochromocytoma, Renal cell carcinoma, Surveillance, von Hippel-Lindau disease, Genetic Predisposition to Disease, von Hippel-Lindau Disease/diagnosis, Humans, Kidney Neoplasms/complications, Hemangioblastoma/diagnosis, Adult, Carcinoma, Renal Cell
وصف الملف: application/pdf
العلاقة: https://pure.au.dk/portal/da/publications/von-hippellindau-diseaseTest(788a7178-27e0-4fc1-a9be-7ef849da5978).html
الإتاحة: https://doi.org/10.1016/j.ejmg.2022.104538Test
https://pure.au.dk/portal/da/publications/von-hippellindau-diseaseTest(788a7178-27e0-4fc1-a9be-7ef849da5978).html
https://pure.au.dk/ws/files/352590286/1-s2.0-S1769721222001197-main.pdfTest
http://www.scopus.com/inward/record.url?scp=85132511144&partnerID=8YFLogxKTest -
3دورية أكاديمية
المؤلفون: Ernst, Matthew, Yuasa, Takeshi, Takemura, Kosuke, Suárez Rodríguez, Cristina, Navani, Vishal, Wells, Connor, Donskov, Frede
المساهمون: Institut Català de la Salut, Navani V, Ernst M Tom Baker Cancer Centre, Department of Medical Oncology, University of Calgary, Calgary, Canada. Wells JC BC Cancer Agency, Vancouver, Canada. Yuasa T Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. Takemura K Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. Donskov F Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. Suarez C Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus
المصدر: Scientia
مصطلحات موضوعية: Ronyons - Càncer - Tractamemt, Factors de creixement, Medicaments antineoplàstics - Ús terapèutic, DISEASES::Neoplasms::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Urologic Neoplasms::Kidney Neoplasms::Carcinoma, Renal Cell, Other subheadings::Other subheadings::Other subheadings::/drug therapy, CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Peptides::Intercellular Signaling Peptides and Proteins::Angiogenic Proteins::Vascular Endothelial Growth Factors::Vascular Endothelial Growth Factor A, Other subheadings::Other subheadings::/therapeutic use, ENFERMEDADES::neoplasias::neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias urológicas::neoplasias renales::carcinoma de células renales, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::péptidos::péptidos y proteínas de señalización intercelular::proteínas angiogénicas::factores de crecimiento endotelial vascular::factor A de crecimiento endotelial vascular, Otros calificadores::Otros calificadores::/uso terapéutico
وصف الملف: application/pdf
العلاقة: JAMA Network Open;5(6); http://dx.doi.org/10.1001/jamanetworkopen.2022.16379Test; Navani V, Ernst M, Wells JC, Yuasa T, Takemura K, Donskov F, et al. Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients With Metastatic Renal Cell Carcinoma. JAMA Netw Open. 2022 Jun 1;5(6):e2216379.; https://hdl.handle.net/11351/8086Test; 000809213100005
الإتاحة: https://doi.org/10.1001/jamanetworkopen.2022.16379Test
https://hdl.handle.net/11351/8086Test -
4دورية أكاديمية
المؤلفون: Lauridsen, Kasper Munch, Hokland, Marianne, Al-Karradi, Sinan, Møller, Holger Jon, Donskov, Frede, Andersen, Morten Nørgaard
المصدر: Lauridsen , K M , Hokland , M , Al-Karradi , S , Møller , H J , Donskov , F & Andersen , M N 2023 , ' Soluble CD163 : a novel independent prognostic biomarker in patients with metastatic renal cell carcinoma ' , Cancer Immunology, Immunotherapy , vol. 72 , no. 2 , pp. 461-473 . https://doi.org/10.1007/s00262-022-03266-6Test
مصطلحات موضوعية: Biomarker, CD163, Monocyte, Renal cell carcinoma, Soluble CD163, Kidney Neoplasms, Prognosis, Humans, Biomarkers, Carcinoma, Renal Cell, Antigens, Differentiation, Myelomonocytic/metabolism
العلاقة: https://portal.findresearcher.sdu.dk/da/publications/bce6cdba-0318-47f3-aeb7-8f85f1dac89dTest
الإتاحة: https://doi.org/10.1007/s00262-022-03266-6Test
https://portal.findresearcher.sdu.dk/da/publications/bce6cdba-0318-47f3-aeb7-8f85f1dac89dTest -
5دورية أكاديمية
المؤلفون: Davis, Ian D, Xie, Wanling, Pezaro, Carmel, Donskov, Frede, Wells, J Connor, Agarwal, Neeraj, Srinivas, Sandy, Yuasa, Takeshi, Beuselinck, Benoit, Wood, Lori A, Ernst, D Scott, Kanesvaran, Ravindran, Knox, Jennifer J, Pantuck, Allan, Saleem, Sadia, Alva, Ajjai, Rini, Brian I, Lee, Jae-Lyun, Choueiri, Toni K, Heng, Daniel Y C
المصدر: Davis , I D , Xie , W , Pezaro , C , Donskov , F , Wells , J C , Agarwal , N , Srinivas , S , Yuasa , T , Beuselinck , B , Wood , L A , Ernst , D S , Kanesvaran , R , Knox , J J , Pantuck , A , Saleem , S , Alva , A , Rini , B I , Lee , J-L , Choueiri , T K & Heng , D Y C 2017 , ' Efficacy of Second-line Targeted Therapy for Renal Cell ....
مصطلحات موضوعية: Carcinoma, Database, Follow-up studies, Logistic models, Renal cell
الإتاحة: https://doi.org/10.1016/j.eururo.2016.09.047Test
https://pure.au.dk/portal/en/publications/3d752f13-223c-4d00-a032-6a99b93e95ecTest -
6دورية أكاديمية
المؤلفون: Motzer, Robert J, Tannir, Nizar M, McDermott, David F, Arén Frontera, Osvaldo, Melichar, Bohuslav, Choueiri, Toni K, Plimack, Elizabeth R, Barthélémy, Philippe, Porta, Camillo, George, Saby, Powles, Thomas, Donskov, Frede, Neiman, Victoria, Kollmannsberger, Christian K, Salman, Pamela, Gurney, Howard, Hawkins, Robert, Ravaud, Alain, Grimm, Marc-Oliver, Bracarda, Sergio, Barrios, Carlos H, Tomita, Yoshihiko, Castellano, Daniel, Rini, Brian I, Chen, Allen C, Mekan, Sabeen, McHenry, M Brent, Wind-Rotolo, Megan, Doan, Justin, Sharma, Padmanee, Hammers, Hans J, Escudier, Bernard
المساهمون: Motzer, Robert J, Tannir, Nizar M, Mcdermott, David F, Arén Frontera, Osvaldo, Melichar, Bohuslav, Choueiri, Toni K, Plimack, Elizabeth R, Barthélémy, Philippe, Porta, Camillo, George, Saby, Powles, Thoma, Donskov, Frede, Neiman, Victoria, Kollmannsberger, Christian K, Salman, Pamela, Gurney, Howard, Hawkins, Robert, Ravaud, Alain, Grimm, Marc-Oliver, Bracarda, Sergio, Barrios, Carlos H, Tomita, Yoshihiko, Castellano, Daniel, Rini, Brian I, Chen, Allen C, Mekan, Sabeen, Mchenry, M Brent, Wind-Rotolo, Megan, Doan, Justin, Sharma, Padmanee, Hammers, Hans J, Escudier, Bernard
مصطلحات موضوعية: Adult, Aged, 80 and over, Antibodies, Monoclonal, Antineoplastic Agents, Immunological, Antineoplastic Combined Chemotherapy Protocol, Carcinoma, Renal Cell, Disease-Free Survival, Human, Indole, Ipilimumab, Kidney Neoplasm, Male, Middle Aged, Nivolumab, Pyrrole, Quality of Life, Risk, Sunitinib, Survival Analysi, Survival Rate
وصف الملف: STAMPA
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/29562145; volume:378; issue:14; firstpage:1277; lastpage:1290; numberofpages:14; journal:NEW ENGLAND JOURNAL OF MEDICINE; http://hdl.handle.net/11571/1258666Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85045136401
-
7دورية أكاديمية
المؤلفون: Motzer, Robert J, Haas, Naomi B, Donskov, Frede, Gross-Goupil, Marine, Varlamov, Sergei, Kopyltsov, Evgeny, Lee, Jae Lyun, Melichar, Bohuslav, Rini, Brian I, Choueiri, Toni K, Zemanova, Milada, Wood, Lori A, Reaume, M Neil, Stenzl, Arnulf, Chowdhury, Simon, Lim, Ho Yeong, McDermott, Ray, Michael, Agnieszka, Bao, Weichao, Carrasco-Alfonso, Marlene J, Aimone, Paola, Voi, Maurizio, Doehn, Christian, Russo, Paul, Sternberg, Cora N
المصدر: Motzer , R J , Haas , N B , Donskov , F , Gross-Goupil , M , Varlamov , S , Kopyltsov , E , Lee , J L , Melichar , B , Rini , B I , Choueiri , T K , Zemanova , M , Wood , L A , Reaume , M N , Stenzl , A , Chowdhury , S , Lim , H Y , McDermott , R , Michael , A , Bao , W , Carrasco-Alfonso , M J , Aimone , P , Voi , M , Doehn , ....
مصطلحات موضوعية: Adult, Aged, 80 and over, Angiogenesis Inhibitors, Carcinoma, Renal Cell, Chemotherapy, Adjuvant, Disease-Free Survival, Dose-Response Relationship, Drug, Female, Humans, Kidney Neoplasms, Male, Middle Aged, Neoplasm Grading, Nephrectomy, Placebos, Pyrimidines, Sulfonamides, Young Adult, Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial
الإتاحة: https://doi.org/10.1200/JCO.2017.73.5324Test
https://pure.au.dk/portal/da/publications/randomized-phase-iii-trial-of-adjuvant-pazopanib-versus-placebo-after-nephrectomy-in-patients-with-localized-or-locally-advanced-renal-cell-carcinomaTest(a8257f36-24f9-433b-a81d-ba9766c6b2b4).html -
8دورية أكاديمية
المؤلفون: Ravaud, Alain, Motzer, Robert J, Pandha, Hardev S, George, Daniel J, Pantuck, Allan J, Patel, Anup, Chang, Yen-Hwa, Escudier, Bernard, Donskov, Frede, Magheli, Ahmed, Carteni, Giacomo, Laguerre, Brigitte, Tomczak, Piotr, Gerletti, Paola, Lechuga, Mariajose, Lin, Xun, Martini, Jean-Francois, Ramaswamy, Krishnan, Casey, Michelle, Staehler, Michael, Patard, Jean-Jacques
المصدر: Ravaud , A , Motzer , R J , Pandha , H S , George , D J , Pantuck , A J , Patel , A , Chang , Y-H , Escudier , B , Donskov , F , Magheli , A , Carteni , G , Laguerre , B , Tomczak , P , Gerletti , P , Lechuga , M , Lin , X , Martini , J-F , Ramaswamy , K , Casey , M , Staehler , M , Patard , J-J & S-TRAC Investigators 2016 , ' Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma ....
مصطلحات موضوعية: Adolescent, Adult, Aged, 80 and over, Antineoplastic Agents, Carcinoma, Renal Cell, Chemotherapy, Adjuvant, Double-Blind Method, Drug Administration Schedule, Female, Humans, Indoles, Kidney Neoplasms, Male, Middle Aged, Nephrectomy, Pyrroles, Survival Analysis, Young Adult, Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial
الإتاحة: https://doi.org/10.1056/NEJMoa1611406Test
https://pure.au.dk/portal/da/publications/adjuvant-sunitinib-in-highrisk-renalcell-carcinoma-after-nephrectomyTest(e60bb34c-e7c5-4333-8247-8443abbd9def).html -
9دورية أكاديمية
المؤلفون: Choueiri, Toni K, Escudier, Bernard, Powles, Thomas, Mainwaring, Paul N, Rini, Brian I, Donskov, Frede, Hammers, Hans, Hutson, Thomas E, Lee, Jae-Lyun, Peltola, Katriina, Roth, Bruce J, Bjarnason, Georg A, Géczi, Lajos, Keam, Bhumsuk, Maroto, Pablo, Heng, Daniel Y C, Schmidinger, Manuela, Kantoff, Philip W, Borgman-Hagey, Anne, Hessel, Colin, Scheffold, Christian, Schwab, Gisela M, Tannir, Nizar M, Motzer, Robert J, Schöffski, Patrick
مصطلحات موضوعية: Adult, Aged, 80 and over, Anilides, Antineoplastic Agents, Carcinoma, Renal Cell, Disease-Free Survival, Everolimus, Female, Humans, Kidney Neoplasms, Male, Middle Aged, Pyridines, Quality of Life, Sirolimus, Survival Analysis
وصف الملف: 545699 bytes; application/pdf
العلاقة: New England Journal of Medicine vol:373 issue:19 pages:1814-23; https://lirias.kuleuven.be/handle/123456789/540820Test; https://lirias.kuleuven.be/bitstream/123456789/540820/1//Cabozantinib+versus+Everolimus+in+Advanced+Renal-Cell+Carcinoma.pdfTest
الإتاحة: https://lirias.kuleuven.be/handle/123456789/540820Test
https://lirias.kuleuven.be/bitstream/123456789/540820/1//Cabozantinib+versus+Everolimus+in+Advanced+Renal-Cell+Carcinoma.pdfTest -
10دورية أكاديمية
المؤلفون: Motzer, Robert J, Escudier, Bernard, McDermott, David F, George, Saby, Hammers, Hans J, Srinivas, Sandhya, Tykodi, Scott S, Sosman, Jeffrey A, Procopio, Giuseppe, Plimack, Elizabeth R, Castellano, Daniel, Choueiri, Toni K, Gurney, Howard, Donskov, Frede, Bono, Petri, Wagstaff, John, Gauler, Thomas C, Ueda, Takeshi, Tomita, Yoshihiko, Schutz, Fabio A, Kollmannsberger, Christian, Larkin, James, Ravaud, Alain, Simon, Jason S, Xu, Li-An, Waxman, Ian M, Sharma, Padmanee
المصدر: Motzer , R J , Escudier , B , McDermott , D F , George , S , Hammers , H J , Srinivas , S , Tykodi , S S , Sosman , J A , Procopio , G , Plimack , E R , Castellano , D , Choueiri , T K , Gurney , H , Donskov , F , Bono , P , Wagstaff , J , Gauler , T C , Ueda , T , Tomita , Y , Schutz , F A , Kollmannsberger , C , Larkin , J , Ravaud , ....
مصطلحات موضوعية: Adolescent, Adult, Aged, 80 and over, Antibodies, Monoclonal, Antineoplastic Agents, Carcinoma, Renal Cell, Everolimus, Female, Humans, Kidney Neoplasms, Male, Middle Aged, Quality of Life, Sirolimus, Survival Analysis, Young Adult
الإتاحة: https://doi.org/10.1056/NEJMoa1510665Test
https://pure.au.dk/portal/da/publications/nivolumab-versus-everolimus-in-advanced-renalcell-carcinomaTest(c3743e4d-f3dd-4c88-8970-01a27857bfa1).html